✦ LIBER ✦

Comparative study of cytosine arabinoside therapy alone and combined with thioguanine, mercaptopurine, or daunorubicin in acute myelocytic leukemia

✍ Scribed by Dr. Robert W. Carey; Manuel Ribas-Mundo; Rose Ruth Ellison; Oliver Glidewell; Stanley T. Lee; Janet Cuttner; Robert N. Levy; Richard Silver; Johannes Blom; Farid Haurani; Charles L. Spurr; John B. Harley; Robert Kyle; John H. Moon; Richard T. Eagan; James H. Holland

Publisher: John Wiley and Sons
Year: 1975
Tongue: English
Weight: 470 KB
Volume: 36
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(197511)36:5<1560::aid-cncr2820360504>3.0.co;2-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of acute myeloid leukemia of c

Treatment of acute myeloid leukemia of childhood with cytosine arabinoside, daunorubicin, prednisolone, and mercaptopurine or thioguanine

✍ Dr. D. I. K. Evans; Patricia H. Morris Jones; C. J. Morley 📂 Article 📅 1975 🏛 John Wiley and Sons 🌐 English ⚖ 379 KB 👁 2 views

Eighteen children with acute myeloid leukemia have been treated with a fourdrug protocol using cytosine arabinoside, daunorubicin, prednisolone, and mercaptopurine or thioguanine. The initial remission rate overall was 78%. Of 15 children who completed a week's treatment, i.e. one complete cycle, 14

The prognostic significance of leukemic

The prognostic significance of leukemic cells clearance kinetics evaluation during the initial course of induction therapy with HAD (homoharringtonine, cytosine arabinoside, daunorubicin) in patients with de novo acute myeloid leukemia

✍ Zhijian Xiao; Hua Xue; Rui Li; Li Zhang; Minghua Yu; Yushu Hao 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 221 KB 👁 1 views